| ²é¿´: 563 | »Ø¸´: 7 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
·ÂÖÆÒ©µÄÁÙ´²
|
|||
| ·ÂÖÆÒ©µÄÁÙ´²ÊÇÔõô×öµÄÄØ,FDA ÒªÇóÊÇÉúÎïµÈЧÐԾ͹»Á衃 |
» ²ÂÄãϲ»¶
¹ãÎ÷Ò½¿Æ´óѧ»ù´¡Ò½Ñ§Ôº×ÔÉíÃâÒß²¡¿ÎÌâ×éÕÐÊÕ»ù´¡Ò½Ñ§¡¢Ò©Ñ§ºÍÉúÎïѧµÈרҵµÄÑо¿Éú
ÒѾÓÐ7È˻ظ´
[ѧϰ×ÊÁÏ·ÖÏí] FAERSÊý¾Ý¿âµÄ²»Á¼·´Ó¦ÍÚ¾ò(ƵÊý·¨/±´Ò¶Ë¹·¨)
ÒѾÓÐ1È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ193È˻ظ´
ÕÐÊÕҽѧ¡¢»ù´¡Ò½Ñ§Ààµ÷¼ÁÑо¿Éú
ÒѾÓÐ0È˻ظ´
ÊÇ·ñÊôÓÚÆ¢ÉöÑôÐéÖ¤
ÒѾÓÐ0È˻ظ´
ÄÔ¹£ÔõôÖÎÁÆ
ÒѾÓÐ3È˻ظ´
ÄÔ¹£ÔõôÖÎÁÆ
ÒѾÓÐ0È˻ظ´
ÉúÎï×éÖ¯ÖÐÓÐÄ¿±ê·ÖÎöÎרÊôÐÔÔõô×ö
ÒѾÓÐ0È˻ظ´
¹ãÎ÷Ò½¿Æ´óѧ»ù´¡Ò½Ñ§Ôº×ÔÉíÃâÒß²¡¿ÎÌâ×éÕÐÊÕ»ù´¡Ò½Ñ§Ïà¹Ø×¨ÒµµÄµ÷¼ÁÑо¿Éú
ÒѾÓÐ2È˻ظ´
5Â¥2007-03-02 09:15:37
guohuiwek
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 541.9
- ºì»¨: 1
- Ìû×Ó: 271
- ÔÚÏß: 23Сʱ
- ³æºÅ: 254538
- ×¢²á: 2006-05-27
- רҵ: ºÏ³ÉÒ©Îﻯѧ

2Â¥2007-02-28 12:10:10
3Â¥2007-02-28 16:04:39
ÐÄÀÁÈçè
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 274.4
- Ìû×Ó: 103
- ÔÚÏß: 39·ÖÖÓ
- ³æºÅ: 231399
- ×¢²á: 2006-03-27
- ÐÔ±ð: MM
- רҵ: ×Éѯ
|
ÓкܶàûÓа취²âѪҩŨ¶ÈµÄ ±ÈÈçÃÉÍÑʯ£¨ÉÌÆ·Ãû½Ð˹Ãܴ£¬ÓÃÓÚÖÎÁƸ¹ÐºµÄ£¬ÁÆÐ§ºÜ²»´íµÄÓ´£¬ÓõÄÊÇÎü¸½µÄÔÀí Ò©ÓÃ̿Ƭ£¬ÓÃÓÚÖÎÁÆÊ³ÎïÖж¾µÄ£¬Ã»ÓÐÊÂÎïÖж¾¹ý²»Ì«Çå³þÁÆÐ§£¬ÓõĺÃÏóÒ²ÊÇÎü¸½µÄÔÀí¡££¨¿´×ÅÄÇЩºÚºÚµÄ¶«Î÷£¬ÔõôÏëÒ²²»¿ÉÄÜÔÚѪҺÀïÍ·°¡£© »¹ÓÐÄÇЩ°±»ùËá£¨ÌØ±ðÊÇÈËÌå×Ô¼º¿ÉÒԺϳÉת»¯µÄ£©£¬ÉúÎïÄܵÈЧ£¿ ÎÒÏë¹ØÓÚÔÛÃÇÖйúÏÖÔÚ¶ÔÁÙ´²ºÍÉúÎïµÈЧµÄÒªÇó¶à°ëҲѧ×ÔÃÀÀû¼á£¬ËùÒÔ·ÂÖÆÒ©ÔÚÃÀ¹úÊÇ·ñ×öÁÙ´²£¬Ê²Ã´ÑùµÄÒ©Òª×öÁÙ´²£¬¾ÍÒª¿´ÎÒÃÇÖйúÏÖÔÚ¶Ô½ø¿ÚÒ©Æ·µÄÒªÇóÓ¦¸ÃÄÜÍÆ²âÒ»¶þÀ²¡£ ²»¹ý½¨Òé¿´¿´Drug Price Competition and Patent Term Restoration Act of 1984 £¬»¹ÓÐElectronic Orange Book£¨Approved Drug Products with Therapeutic Equivalence Evaluations£©£¬Ò»°ã·ÂÖÆÒ©Èç¹ûÊÇÊÕÔØÔÚéÙÆ¤ÊéÀïÍ·£¬Ê®Óа˾ÅÊÇÖ»ÓÃ×öÉúÎïµÈЧµÄÀ²£¡ |

4Â¥2007-03-01 17:12:17














»Ø¸´´ËÂ¥